Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia

Blood. 2020 Dec 3;136(23):2715-2719. doi: 10.1182/blood.2020005498.
No abstract available

Publication types

  • Clinical Trial
  • Observational Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Disease-Free Survival
  • Female
  • Geriatric Assessment*
  • Humans
  • Leukemia, Myeloid, Acute* / blood
  • Leukemia, Myeloid, Acute* / mortality
  • Leukemia, Myeloid, Acute* / therapy
  • Male
  • Middle Aged
  • Prospective Studies
  • Survival Rate